European Value Added of Basic Pharmaceutical Products and Pharmaceutical Preparations by Country

The European value added of basic pharmaceutical products and preparations shows notable country-specific performance. In 2023, Germany leads with significant economic contributions, followed by France and Belgium. Germany experienced a modest growth of 1.71%, reflecting its robust pharmaceutical industry. Belgium's value added surged by 7.49%, highlighting its growing importance. Italy and Austria also showed commendable growth, while Finland witnessed a notable increase of 3.36%, suggesting an expanding sector. The smaller economies like Slovenia and Greece also contributed but to a lesser extent. Overall, trends over the last five years suggest a steady compound annual growth rate in these countries’ pharmaceutical sectors.

Future trends to watch include:

• Technical innovations driving sector expansion in Germany and Belgium.
• Pooled investments and collaborations between EU countries to foster pharmaceutical R&D.
• Adoption of digital health technologies enhancing pharmaceutical formulations.
• Regulatory changes impacting production and value addition across the EU.